Spasmalgon tabs #20

Spasmalgon instruction for use

You can buy Spasmalgon on this page

The drug Spasmalgon belongs to the group of spasmoanalgets and is used in many directions of medicine to eliminate pain syndrome and spasms of smooth muscles.

Form of formulation and composition of the preparation

Spasmalgon is available in the form of oral tablets and a solution for injection.
Tablets are round, white with a risk on one side, are issued in blisters of 10 pieces for 1-5 blisters in a cardboard bundle with the accompanying instruction. Each tablet contains 500 mg of metamizole sodium, 5 mg of pituitary hydrochloride, 100 μg of fenpiperinium bromide, and a number of auxiliary components: wheat starch, gelatin, magnesium stearate, lactose monohydrate.
The injection solution is available in ampoules of dark glass in a volume of 2 ml and 5 ml. Ampoules are packed in plastic pallets of 10 pieces in a cardboard box with the attached instructions. The 2 ml ampoule contains:
    Metamizole sodium - 1 g (2.5 g in a 5 ml ampoule);
    Fentivirinium bromide is 40 μg (100 μg in 5 ml);
    Pitophenone hydrochloride - 4 mg (10 mg in 5 ml).
As an auxiliary substance - sterile water for injection.

Indications for use

The drug Spasmalgon is prescribed to patients for relief of pain and spasms of varying intensity. The main indications for use are:
    renal or hepatic colic;
    stitching pain in the intestine;
    ischialgia;
    myalgia;
    painful menstruation.
Tablets and injections Spasmalgon is assigned to patients as part of complex therapy for joint diseases, and as an auxiliary in the postoperative period to reduce the intensity of pain.
Spasmalgon has antipyretic effect, therefore it can be used as a part of complex therapy for ARVI and infectious diseases, accompanied by an increase in body temperature.

Contraindications

Before the start of therapy, it is recommended that you carefully read the instructions for the drug. Spasmalgon should not be taken or injected in the following cases:
    individual intolerance of components included in the formulation;
    lactase deficiency or congenital lactose intolerance (for the drug in the form of tablets);
    oppression of bone marrow circulation;
    angina pectoris;
    heart failure in the stage of decompensation;
    angle-closure glaucoma;
    severe liver and kidney disease, accompanied by a violation of the function of the body;
    suspicion of intestinal obstruction;
    pregnancy in 1 and 3 trimesters;
    the period of breastfeeding;
    severe hypotension;
    hyperplasia of the prostate;
    age of child under 6 years.
The drug is cautiously prescribed to persons prone to developing bronchospasm and hypersensitivity to non-narcotic group analgesics.

Dosing and Administration

Spasmalgon tablets are intended for patients over 12 years of age after oral ingestion. Depending on the indications and individual characteristics of the body, the dose of the drug is calculated by the doctor, according to the instructions the maximum daily dose should not exceed 6 tablets. Children younger than 12 years of age, the dose of the drug is determined exclusively individually, based on the characteristics of the body and body weight.
Solution for injection Spasmalgon is administered intravenously or intramuscularly for 2-5 ml (maximum 10 ml per day). Before the introduction of the drug should warm the ampoule in the palms to body temperature.
The total duration of treatment with Spasmalgon is 5 days, for children no longer than 3 days. In the absence of the expected therapeutic effect, the patient should consult a physician again.

Use during pregnancy and lactation

The drug Spasmalgon is contraindicated for use in the 1st trimester of pregnancy and in the 3rd trimester. In the first 12 weeks, the use of the drug may provoke the development of anomalies and birth defects in the embryo, and the use of Spasmalgon after 32 weeks increases the risk of developing fetal and neonatal disorders of hematopoiesis, malfunctioning of the heart, respiratory system disorders.
The use of the drug in the second trimester of pregnancy is possible only if there are serious indications, if the benefit to the mother exceeds the possible risks to the fetus. Data on the safety of the drug for the fetus at this gestation period are not provided, so treatment must be coordinated with the doctor.
Active active substances of the drug Spasmalgon penetrate into breast milk, so the combination of lactation and drug therapy is impossible to avoid the development of complications from the infants. If necessary, therapy, a woman should stop breastfeeding.

Adverse Events

When the recommended dose of the drug is well tolerated. In persons with hypersensitivity, there may be side effects on the background of therapy:
    from the nervous system: dizziness, lethargy, apathy, drowsiness, paresis, decreased sweating;
    from the side of the digestive canal: dry mouth, nausea, epigastric pain, vomiting, flatulence, constipation, pain in the right hypochondrium;
    on the part of the cardiovascular system: a decrease in blood pressure, heart palpitations, dyspnea, threadlike pulse, blue limbs and nasolabial triangle;
    on the part of the blood system: a decrease in the level of platelets, leukocytes, agranulocytosis;
    from the side of urinary organs: disrupting the work of the kidneys, reducing diurnal diuresis, anuria, the appearance of protein in the urine, hematuria;
    allergic reactions: Quincke's edema, urticaria, rash on the skin, dermatitis, erythema, Lyell's syndrome, anaphylactic shock.
A side effect of the injectable drug Spasmalgon is burning at the injection site, swelling of the tissues, hematoma, the formation of an infiltrate.

An overdose of the drug

If the dose recommended by the doctor is exceeded, the patient has signs of an overdose:
    dry mouth;
    nausea and vomiting;
    rapid drop in blood pressure;
    decreased sweating;
    confusion of consciousness;
    tachycardia;
    convulsions;
    development of renal and hepatic insufficiency.
In case of signs of overdose, the patient should be taken to a hospital where the stomach is washed, sorbents are introduced and symptomatic treatment is carried out if necessary.

Interaction of the drug with other drugs

The drug Spasmalgon should not be given to patients at the same time as other analgesics or antispasmodics, as this increases the risk of side effects and overdose.
When the drug is combined with oral hormonal contraceptives, tricyclic antidepressants and allopurinol, the toxic effect of metamizole on the liver increases, which should be taken into account and avoid such drug interactions.
Simultaneous use of sedatives and Spasmalgon enhances the therapeutic effect of the latter.
The combination of the drug with indirect anticoagulants, indometacin or glucocorticosteroids increases the therapeutic effect of the latter. The interaction of Spasmalgon with drugs from the group of cytostatics increases the risk of developing leukopenia.

special instructions

When using the drug for more than 5 days, it is necessary to pass tests for monitoring the level of platelets and leukocytes, as well as liver transaminases. With the detection of thrombocytopenia or agranulocytosis, spasmalgon should be discontinued immediately.
During the period of drug therapy, it is forbidden to drink alcoholic beverages, as this increases the risk of toxic damage to the liver and kidneys.
Against the backdrop of Spasmalgon, patients may experience dizziness, decreased blood pressure and drowsiness. In view of these data, therapy with the drug is not recommended to be combined with driving a car and managing complex equipment requiring increased concentration of attention.

Terms of storage

The shelf life of the drug is indicated on the package. The solution for injections should be stored in a cool dark place for no more than 2 years. If the consistency of the solution changes, precipitation or suspension in the ampoule, the drug should not be used.
Tablets can be stored at room temperature, 3 years from the date of production.